Antiplatelet agents: how much? which one? for whom?
Gomes, O.M.
Arquivos Brasileiros de Cardiologia 38(1): 1-2
1982
ISSN/ISBN: 0066-782X PMID: 7150049 Document Number: 186238
Document emailed within 1 workday
Related Documents
Coccheri, S. 2013: New antiplatelet agents: are we better off now than we were with aspirin? Clinical Advances in Hematology and Oncology: H&o 11(12): 787-790Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653
De Caterina, R.; Blanco, A. 1992: Nitrates as antiplatelet agents Sangre 37(1): 31-38
De Gautard, G.; Perrier, A. 2014: Antiplatelet agents in secondary prevention of stroke Revue Medicale Suisse 10(446): 1902 1904-7
Bochenek, A.; Wilczyński, M.ła. 2006: Antiplatelet agents--problem for cardiac surgeon Kardiologia Polska 64(11): 1329-1331
Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17
Zoja, C.; Perico, N.; Remuzzi, G. 1991: Antiplatelet agents: effects on the progressive renal disease American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 17(5 Suppl 1: 98-102
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Satoh, S. 2011: Usage of antiplatelet and anticoagulant agents in ischemic cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 423-427
Teng, C.M.; Ko, F.N.; Wang, J.P.; Lin, C.N.; Wu, T.S.; Chen, C.C.; Huang, T.F. 1991: Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs Journal of Pharmacy and Pharmacology 43(9): 667-669
Schaerlig, E. 2010: Echoes of the ESC 2010. Atrial fibrillation, rush on antiplatelet agents, genetics omnipresence Revue medicale suisse 6(270): 2151-2152
Melandri, G.; Semprini, F.; Cervi, V.; Candiotti, N.; Branzi, A. 1994: Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment Cardiologia 39(12 Suppl. 1): 347-352
Bussey, H.I. 2004: An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves Journal of Heart Valve Disease 13(3): 319-324
Kawana, S.; Katori, M.; Ohta, M.; Nishiyama, S. 1986: Microcirculatory changes during skin allograft rejection and prolongation of survival time by antiplatelet agents International Journal of Tissue Reactions 8(2): 119-128
Wang, Y.-m.; Cao, Y.-j.; Liu, C.-f.; Feng, P. 2007: The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction Zhonghua Nei Ke Za Zhi 46(7): 562-565
Lam, S.C.; Dieter, J.P.; Strebel, L.C.; Taylor, T.M.; Muscolino, G.; Feinberg, H.; Le Breton, G.C. 1991: Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents Journal of Pharmacology and Experimental Therapeutics 259(3): 1371-1378
Khitin, L.M.; Sade, R.M.; Bradley, S.M.; Crawford, F.A.; Widener, C.E.; Stroud, M.R. 2006: Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents Journal of Heart Valve Disease 15(3): 394-9; Discussion 399
Hostetter, J.C.; Bhatt, D.L. 2003: The expanding role of antiplatelet agents in coronary artery disease. a current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines Minerva Cardioangiologica 51(5): 531-546
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Popova, L.V.; Aksenova, M.B.; Khlevchuk, T.V. 2016: Antiplatelet therapy in cardiology Klinicheskaia Meditsina 94(10): 729-736